Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. 4 giorni fa · Affiliations 1 Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Germany; member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Germany (M.M.H., K.M.O.).

  2. 4 giorni fa · Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Germany; member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Germany (M.M.H., K.M.O.).

  3. 4 giorni fa · Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany. Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada. Department of Bioethics, Medical University of Warsaw, Warsaw, Poland. Search for more papers by this author

  4. 1 giorno fa · A total of 30 consecutive cases of breast cancer patients from the Interdisciplinary Gynecologic Tumor Board of the Hannover Medical School in 2022 were used for evaluation via ChatGPT (GPT 3.5). We included patients with primary or recurrent invasive breast cancer. Cases with already completed therapy were excluded.

  5. 1 giorno fa · “Based on the clinical benefits demonstrated in primary and secondary outcome measures in the Phase 3 STELLAR study, Winrevair has the potential to play a critical role in the treatment of appropriate adults with PAH,” said Marius Hoeper, MD, acting director of the department of respiratory medicine and infectious diseases at Hannover Medical School in Germany.

  6. 4 giorni fa · “WINREVAIR is the first activin signaling inhibitor therapy and is proposed to modulate the vascular proliferation underlying PAH,” said Dr. Marius Hoeper, Hannover Medical School, Germany.

  7. www.merck.com › news › merck-receives-positive-eu-chmp-opinionWhat can we help you find? - Merck

    3 giorni fa · “WINREVAIR is the first activin signaling inhibitor therapy and is proposed to modulate the vascular proliferation underlying PAH,” said Dr. Marius Hoeper, Hannover Medical School, Germany. “Based on the clinical benefits demonstrated in primary and secondary outcome measures in the Phase 3 STELLAR study, WINREVAIR has the potential to play a critical role in the treatment of appropriate ...

  1. Annuncio

    relativo a: Hannover Medical School
  2. We Researched It For You: Medical Schools, Medical Schools, Medical School. School Of Medicine, Medical Schools In The United States & more. View them Now!